Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SPCX
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
SNDK
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.53% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Benitec Biopharma
BNTC
$390M
| $12.3M | ﹤0.01% |
921,299
+269,235
| +41% | +$3.19M |
|
2002
Box
BOX
$4.76B
| $12.3M | ﹤0.01% |
464,207
-314,615
| -40% | -$7.85M |
|
2003
PUT
Phillips 66
PSX
$108B
| $12.3M | ﹤0.01% |
72,800
+2,500
| +4% | +$430K |
|
2004
ACI Worldwide
ACIW
$5.17B
| $12.3M | ﹤0.01% |
244,164
+213,697
| +701% | +$9.29M |
|
2005
C.H. Robinson
CHRW
$18B
| $12.3M | ﹤0.01% |
65,075
-411,482
| -86% | -$73.1M |
|
2006
Omnicom Group
OMC
$21.7B
| $12.2M | ﹤0.01% |
167,822
-58,227
| -26% | -$4.38M |
|
2007
Agilent Technologies
A
$43.8B
| $12.2M | ﹤0.01% |
91,938
-594,608
| -87% | -$72.5M |
|
2008
CALL
Sony
SONY
$139B
| $12.2M | ﹤0.01% |
608,600
-275,100
| -31% | -$5.8M |
|
2009
PUT
Moderna
MRNA
$62B
| $12.2M | ﹤0.01% |
174,300
+18,500
| +12% | +$957K |
|
2010
Rogers Communications
RCI
$19.2B
| $12.2M | ﹤0.01% |
375,575
+321,297
| +592% | +$11.6M |
|
|
OCTV
2011
Octave Intelligence
OCTV
$4.95B
| $12.2M | ﹤0.01% |
+748,355
| New | +$13.7M |
|
|
FLY
2012
Firefly Aerospace
FLY
$3.66B
| $12.2M | ﹤0.01% |
414,331
+83,434
| +25% | +$3.12M |
|
2013
CALL
Liberty Media Series C
FWONK
$23.7B
| $12.2M | ﹤0.01% |
128,000
+114,400
| +841% | +$10.2M |
|
2014
PUT
Edwards Lifesciences
EW
$50.9B
| $12.2M | ﹤0.01% |
134,600
+67,100
| +99% | +$5.62M |
|
|
SION
2015
Sionna Therapeutics
SION
$348M
| $12.2M | ﹤0.01% |
276,733
+136,092
| +97% | +$5.44M |
|
2016
Unilever
UL
$134B
| $12.2M | ﹤0.01% |
202,457
-277,562
| -58% | -$16M |
|
2017
Jabil
JBL
$31.3B
| $12.2M | ﹤0.01% |
31,553
-53,474
| -63% | -$18.5M |
|
2018
Sutro Biopharma
STRO
$255M
| $12.2M | ﹤0.01% |
365,972
+155,594
| +74% | +$4.85M |
|
2019
DNOW Inc
DNOW
$2.89B
| $12.1M | ﹤0.01% |
934,594
+646,069
| +224% | +$8.39M |
|
2020
Brookfield Renewable
BEPC
$5.54B
| $12.1M | ﹤0.01% |
326,160
+203,402
| +166% | +$7.88M |
|
2021
CALL
Quanta Services
PWR
$92.6B
| $12.1M | ﹤0.01% |
16,800
+1,900
| +13% | +$1.3M |
|
2022
ManpowerGroup
MAN
$2.67B
| $12.1M | ﹤0.01% |
357,783
+96,377
| +37% | +$2.95M |
|
2023
Transcat
TRNS
$802M
| $12.1M | ﹤0.01% |
130,212
+58,783
| +82% | +$4.8M |
|
2024
PUT
Archer Daniels Midland
ADM
$42.4B
| $12.1M | ﹤0.01% |
158,100
+71,900
| +83% | +$5.47M |
|
2025
Reinsurance Group of America
RGA
$16.2B
| $12.1M | ﹤0.01% |
56,744
-198,279
| -78% | -$41.4M |
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.